ArticleCell reports. Medicine2025

AZ14289671 is a highly selective and blood-brain barrier penetrant irreversible TKI that targets EGFRExon20 insertions.

Aisha M Swaih et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.